InCandida albicans, resistance to flucytosine and terbinafine is linked toMAT locus homozygosity and multilocus sequence typing clade 1-Reference-Cited by-同舟云学术

InCandida albicans, resistance to flucytosine and terbinafine is linked toMAT locus homozygosity and multilocus sequence typing clade 1

Published:2009-11 Issue:7 Volume:9 Page:1091-1101
ISSN:1567-1356
Container-title:FEMS Yeast Research
language:en
Short-container-title:

Author:

Odds Frank C.

Publisher

Oxford University Press (OUP)

Subject

Applied Microbiology and Biotechnology,General Medicine,Microbiology

Link

http://academic.oup.com/femsyr/article-pdf/9/7/1091/18019698/9-7-1091.pdf

Reference40 articles.

1. Balfour JA & Faulds D (1992) Terbinafine - a review of its pharmacodynamic and pharmacokinetic properties; and therapeutic potential in superficial mycoses. Drugs 43: 259-284.

2. Barchiesi F , DiFrancesco LF & Scalise G (1997) In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Ch 41: 1812-1814.

3. Blignaut E , Molepoa J , Pujol C , Soll DR & Pfaller MA (2005) Clade-related amphotericin B resistance among South African Candida albicans isolates. Diagn Micr Infec Dis 53: 29-31.

4. Bougnoux ME , Tavanti A , Bouchier C et al. (2003) Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol 41: 5265-5266.

5. Canton E , Peman J , Gobernado M , Viudes A & Espinel-Ingroff A (2005) Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods. Antimicrob Agents Ch 49: 1593-1596.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal susceptibility testing following the CLSI M27 document, along with the measurement of MFC/MIC ratio, could be the optimal approach to detect amphotericin B resistance in Clavispora ( Candida ) lusitaniae . Susceptibility patterns of contemporary isolates of this species;Antimicrobial Agents and Chemotherapy;2024-01-10

2. Fungal cell barriers and organelles are disrupted by polyhexamethylene biguanide (PHMB);Scientific Reports;2023-02-16

3. Emergence of Antifungal Resistant Subclades in the Global Predominant Phylogenetic Population of Candida albicans;Microbiology Spectrum;2023-02-14

4. Candida albicans Multilocus Sequence Typing Clade I Contributes to the Clinical Phenotype of Vulvovaginal Candidiasis Patients;Frontiers in Medicine;2022-04-01

5. Looking for New Antifungal Drugs from Flavonoids: Impact of the Genetic Diversity of Candida albicans on the in-vitro Response;Current Medicinal Chemistry;2019-10-23